DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B
- Keun-Wook Lee
- Devalingam Mahalingam
- Byoung Yong Shim
- In-Ho Kim
- Do-Youn Oh
- Hope Uronis
- Sun Jin Sym
- Mohamad Sonbol
- Khaldoun Almhanna
- Mohamedtaki A. Tejani
- Beodeul Kang
- Michael H. Kagey
- Melissa Stilian
- Calvin Jia
- Cynthia A. Sirard
- Rachel Altura
- Jaffer A. Ajani
- Samuel J. Klempner
2025-07-10